Stock Update (NYSE:PFE): Pfizer Announces FDA Acceptance Of Palbociclib New Drug Application With Priority Review

[Business Wire] – Pfizer Inc. today announced the New Drug Application for palbociclib has been accepted for filing and granted Priority Review by the United States Food and Drug Administration . Read more . . . → Read More: Stock Update (NYSE:PFE): Pfizer Announces FDA Acceptance Of Palbociclib New Drug Application With Priority Review Similar Articles: Company Update: Pfizer Inc (NYSE:PFE) – Pfizer Completes Acquisition Of InnoPharma Pfizer Inc (NYSE:PFE) – French biotech Cellectis surges as Pfizer signs cancer drug deal Market Update: Pfizer Inc (NYSE:PFE) – AstraZeneca in partnering talks for Alzheimer’s drug